CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-30 | Snow David P. CHIEF BUSINESS OFFICER | Option exercise | +6,250 | 6,250 | ||
| 2020-01-30 | Snow David P. CHIEF BUSINESS OFFICER | Shares withheld for taxes | −2,045 | $3.91 | $8K | 4,205 |
| 2020-01-30 | Snow David P. CHIEF BUSINESS OFFICER | Option exercise · Restricted Stock Units | +6,250 | 18,750 | ||
| 2020-01-30 | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | Option exercise | +6,250 | 6,250 | ||
| 2020-01-30 | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | Shares withheld for taxes | −2,166 | $3.91 | $8K | 4,084 |
| 2020-01-30 | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | Option exercise · Restricted Stock Units | +6,250 | 18,750 |
Page 11 of 11 · 206 trades